A Phase II Double-blind Randomised, Placebo-controlled Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

Trial Profile

A Phase II Double-blind Randomised, Placebo-controlled Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2017

At a glance

  • Drugs Nitazoxanide (Primary)
  • Indications Bronchiolitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2017.
    • 10 Oct 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 03 May 2016 Planned initiation date changed from 1 Jul 2015 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top